Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?
about
HPV-associated head and neck cancer: a virus-related cancer epidemic.Combined P16 and human papillomavirus testing predicts head and neck cancer survival.Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review.Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancerHPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease.Biomarkers of HPV in head and neck squamous cell carcinoma.Autoantibodies in cancer: prognostic biomarkers and immune activation.Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly.Statistical analysis of human papillomavirus in a subset of upper aerodigestive tract tumors.Detection of human papillomavirus in laryngeal squamous cell carcinoma: Systematic review and meta-analysis.p16INK4a : A surrogate marker of high-risk human papillomavirus infection in squamous cell carcinoma of the nasal vestibule.Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers.Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.
P2860
Q34114152-25F98315-1735-4276-B243-D9CED1F1BB04Q34156725-E5343EB2-8AC4-4915-9166-C50F5D466F74Q34287177-40E55C8D-865E-4B58-956C-E209F2CF048EQ35034741-2574BDF9-FD2A-4814-A9C6-2470416D2A11Q35688600-CEABD0EE-742E-4B26-BD3D-6E3334FF95EAQ35725063-0C445DEC-8588-488C-A068-C0EDA7CA1DBAQ36295974-940E4702-C154-4FDF-BA78-2FBE892EEDC4Q37945787-CD8694E3-9F76-4335-B015-2919A73C500AQ37948702-44B1525B-7D16-41BE-B810-7D713FDE6AA9Q38122122-DAE5CEFA-1D39-4F68-82A4-296C764AD0DAQ38626463-07350C48-F3E1-4C56-ACCE-D7817C75AAA2Q40260945-466F1E84-469C-47A3-B613-5949BDDF672FQ42240378-804F423F-37F3-446A-8443-6AE2081A3956Q43252012-C3AABC50-6854-479C-B5AB-3BCF7C309F15Q43653961-EC87812B-09CF-48AF-BC25-86119A72FEF3Q54393225-65EE76A9-C1B5-44AB-9BB1-624E36E17DC0
P2860
Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Does pretreatment seropositivi ...... nce for head and neck cancers?
@ast
Does pretreatment seropositivi ...... nce for head and neck cancers?
@en
type
label
Does pretreatment seropositivi ...... nce for head and neck cancers?
@ast
Does pretreatment seropositivi ...... nce for head and neck cancers?
@en
prefLabel
Does pretreatment seropositivi ...... nce for head and neck cancers?
@ast
Does pretreatment seropositivi ...... nce for head and neck cancers?
@en
P2093
P2860
P1476
Does pretreatment seropositivi ...... nce for head and neck cancers?
@en
P2093
Elaine M Smith
Eva Hamsikova
John H Lee
Justine M Ritchie
Linda M Rubenstein
Lubomir P Turek
Thomas H Haugen
P2860
P304
P356
10.1158/1055-9965.EPI-08-0054
P577
2008-08-01T00:00:00Z